All In MedTech

Device Trial Radar · NCT07927985

RESTORE: Restoring State-dependent Thalamocortical Oscillations in Epilepsy

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Nov 25, 2026

Primary completion

Nov 25, 2029

Study completion Nov 15, 2030

Sponsor

Lead sponsor
Gregory WorrellAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 10, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to determine the safety and effectiveness of the investigational Cadence Biomarker Targeted Stimulation (BTS) System (Model 5100 EEG Workstation and Alera Model 2000 Biomarker Stimulation System), when used to reduce the frequency of seizures in patients with generalized onset epilepsy.

Conditions

  • Epilepsy, Drug Resistant

Interventions

  • Sham Mediodorsal Thalamic (MD) Deep Brain Stimulation + Centromedian Thalamic (CM) Deep Brain StimulationDevice

    The implanted Cadence BTS System is programmed so that no therapeutic MD stimulation is delivered during the 3-month sham period. Optimized centromedian nucleus thalamus (CM) stimulation continues. This intervention is administered once to every participant in the period specified by the assigned sequence.

  • Low-Frequency Mediodorsal Thalamic Deep Brain StimulationDevice

    The implanted Cadence BTS System delivers protocol-defined low-frequency stimulation to the bilateral MD thalamic nuclei for 3 months while optimized CM stimulation continues. This intervention is administered once to every participant in the period specified by the assigned sequence.

  • High-Frequency Mediodorsal Thalamic Deep Brain StimulationDevice

    The implanted Cadence BTS System delivers protocol-defined high-frequency stimulation to the bilateral MD thalamic nuclei for 3 months while optimized CM stimulation continues. This intervention is administered once to every participant in the period specified by the assigned sequence.

  • Mediodorsal Thalamic Deep Brain Stimulation using optimal settingsDevice

    After the randomized periods, all participants enter an open-label phase and receive the stimulation settings selected as optimal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With a Device, Procedure, or Stimulation-Related Serious Adverse EventsTime frame: From device implantation through Month 21

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.